Adverse Selection

Adverse selection is a phenomenon in the insurance industry that occurs when policyholders who are at a higher risk of making a claim are more likely to purchase insurance than those who are at a lower risk. This can result in insurers facing a disproportionate number of high-risk policyholders, which can lead to higher claim payouts and increased costs for the insurer.

Some key features of adverse selection in the insurance industry include:

  • Higher risk policyholders: Adverse selection occurs when policyholders who are at a higher risk of making a claim are more likely to purchase insurance. For example, people with a history of health problems are more likely to purchase health insurance than those who are healthy.

  • Unbalanced risk pool: When a disproportionate number of high-risk policyholders purchase insurance, it can result in an unbalanced risk pool. This means that the insurer may be paying out more in claims than it is receiving in premiums.

  • Premium increases: To offset the higher costs associated with an unbalanced risk pool, insurers may need to increase premiums for all policyholders. This can lead to a situation where even low-risk policyholders are paying higher premiums than they would otherwise.

  • Limited coverage: To manage their risk exposure, insurers may limit coverage for certain high-risk groups. For example, an insurer may exclude coverage for pre-existing medical conditions in a health insurance policy.

For example, imagine an auto insurance company offers a standard policy with a $1,000 premium. The policy covers both high-risk and low-risk drivers. However, high-risk drivers are more likely to purchase the policy than low-risk drivers because they anticipate higher expenses in case of an accident. Over time, the insurance company's pool of policyholders becomes increasingly high-risk. To offset this, the insurance company may need to raise premiums to cover the higher expected costs, which could further drive away low-risk drivers and perpetuate the adverse selection cycle.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.